Loading chat...
IN HB1382
Bill
Status
1/14/2015
Primary Sponsor
Gail Riecken
Click for details
AI Summary
HB 1382 Summary
-
Classifies ephedrine and pseudoephedrine as Schedule III controlled substances, requiring prescription for dispensing effective July 1, 2015
-
Repeals existing over-the-counter sales provisions for ephedrine and pseudoephedrine drugs, including definitions and regulations governing non-prescription retail sales
-
Repeals associated definitions from Indiana Code including "constant video monitoring," "convenience package," "retailer," "suspicious order," and "unusual theft" related to over-the-counter sales tracking
-
Amends controlled substance possession laws to align with the Schedule III classification, maintaining criminal penalties for unauthorized possession
-
Repeals IC 35-48-4-14.7, which had established a regulatory framework for pharmacy and retailer sales of ephedrine and pseudoephedrine products without prescriptions
Legislative Description
Ephedrine and pseudoephedrine. Provides that materials, compounds, mixtures, or preparations that contain ephedrine or pseudoephedrine are schedule III controlled substances that may be dispensed only by prescription. Repeals: (1) the law concerning the sale of drugs that contain ephedrine and pseudoephedrine without a prescription; and (2) provisions related to that law.
Last Action
First Reading: referred to Committee on Public Health
1/14/2015